#United States #Alexandria #Bluesight #ControlCheck #Protenus

Bluesight Receives Prestigious KLAS Awards for Excellence in Healthcare Solutions

Bluesight, a leading provider of intelligent hospital solutions, has recently secured recognition as the Best in KLAS in two distinct categories: Drug Diversion Monitoring and Patient Privacy. This accolade highlights Bluesight's commitment to delivering innovative solutions that ultimately enhance patient care.

In the 2025 Best in KLAS Software & Services report, KLAS Research evaluated numerous healthcare technology firms and determined that Bluesight's ControlCheck achieved an impressive score of 86.1, while its patient privacy monitoring solution garnered an outstanding score of 94.3. Both scores are significant and reflect the satisfaction and trust that healthcare professionals place in Bluesight’s offerings.

Commitment to Healthcare Innovation

Kevin MacDonald, CEO and Co-Founder of Bluesight, expressed his gratitude for the recognition, emphasizing the company's dedication to understanding and addressing customer needs. "We are honored to be recognized by KLAS for our ControlCheck and patient privacy monitoring solutions. This award is a testament to our strategy and all of the hard work by our team to deliver on this mission," he stated.

The accolades follow Bluesight's recent acquisition of Protenus, which has now been integrated into Bluesight’s product suite. This acquisition allows them to provide a more comprehensive solution tailored to the complexities of modern healthcare operations. ControlCheck offers users a robust workflow that not only helps to prevent drug diversion but also enhances monitoring across various healthcare settings, including nursing and pharmacy environments.

Enhancing Patient Security and Compliance

Combining ControlCheck with the Protenus patient privacy monitoring solution, Bluesight has developed a powerful platform that secures healthcare operations by automating key monitoring tasks. The Protenus monitoring solution employs advanced machine learning techniques to detect potential privacy violations reliably. This kind of proactive monitoring helps organizations identify any inappropriate access to patient information, enabling them to swiftly address potential breaches before they escalate.

The integration of these innovative technologies underscores a transformative approach in healthcare compliance, as it reduces the workload for compliance stakeholders and maximizes their ability to implement effective risk management practices. By minimizing false positives and false negatives, Bluesight’s solutions provide a more accurate assessment of potential risks related to drug diversion and patient privacy breaches.

Future Outlook

Looking ahead, Bluesight aims to expand its offerings even further to create a seamless continuum of care that automates additional workflows. Kevin MacDonald mentioned that Bluesight’s vision is not only focused on maintaining high standards but also on advancing healthcare solutions across multiple fronts, ensuring better patient outcomes, reduced risks, and enhanced operational efficiencies.

For anyone interested in learning more about Bluesight’s impressive line-up of solutions, additional information is available on their official website.

The complete 2025 Best in KLAS report can also be accessed at KLAS Research's website. These acknowledgments not only confirm Bluesight's place as an industry leader but also strengthen the company's commitment to optimizing hospital operations through intelligence and innovation. With over 2,400 healthcare institutions across the U.S. and Canada counting on Bluesight, the company is poised to lead the charge towards a more secure and efficient healthcare landscape.